Hunan Nucien Pharmaceutical Co. Ltd. Class ASSE: 688189

"Hunan Nucien Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

Aug 31, 2026 · Issued by Hunan Nucien Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Hunan Nucien Pharmaceutical Co. Ltd. Class A

"Hunan Nucien Pharmaceutical Co., Ltd."Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance BriefingAug 26
"Hunan Nucien Pharmaceutical Co., Ltd."Announcement on Appointment of General ManagerAug 22
"Hunan Nucien Pharmaceutical Co., Ltd."Announcement on the Receipt of Warning Letters by the Company and Relevant Responsible PersonsAug 14
"Hunan Nucien Pharmaceutical Co., Ltd."Announcement on Reduction of Registered Capital, Amendment of the Articles of Association, and Completion of Industrial and Commercial Registration ChangesAug 11

All Hunan Nucien Pharmaceutical Co. Ltd. Class A news releases